Avantor® to Participate in KeyBanc Life Sciences and Medtech Investor Forum

RADNOR, Pa., March 8, 2022 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the KeyBanc Life Sciences and Medtech Investor Forum being held virtually on Tuesday, March 22, 2022. Dr. Ger Brophy, Executive Vice President, Biopharma Production at Avantor, will discuss the Company’s biopharma production business and its priorities in the fireside chat segment beginning at approximately 2:15 p.m. Eastern Daylight Time.

A live webcast can be accessed on the investors section of Avantor’s website and a replay will be available through April 22, 2022.

About Avantor
Avantor^®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit www.avantorsciences.com.

Media Contact
Allison Hosak
Senior Vice President, Global Communications and Brand
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com

Investor Relations Contact
Tommy Thomas
Vice President, Investor Relations
Avantor
781-375-8051
Tommy.Thomas@avantorsciences.com

View original content:https://www.prnewswire.com/news-releases/avantor-to-participate-in-keybanc-life-sciences-and-medtech-investor-forum-301497003.html

SOURCE Avantor and Financial News